Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Biostar Pharmaceuticals, Inc. Regains Compliance with NASDAQ's Minimum Bid Price Requirement

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/21/2012 | 02:16am CET

Biostar Pharmaceuticals, Inc. Regains Compliance with NASDAQ's Minimum Bid Price Requirement

XIANYANG, China, April 20, 2012/PRNewswire-Asia/ -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in Chinafor a variety of diseases and conditions, today announced that it has received written notification from the Nasdaq Listing Qualifications department that it has regained compliance with the minimum bid price requirement of $1.00per share for continued listing of its common stock on The NASDAQ Global Market set forth in Nasdaq Listing Rule 5450(a)(1), as its common shares achieved a closing bid price of $1.00or more for 10 consecutive business days prior to the compliance deadline of April 23, 2012and this matter is now closed.

About Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc., through its wholly owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company's most popular product is its Xin Aoxing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. For more information please visit: http://www.biostarpharmaceuticals.com

Safe Harbor relating to the Forward-Looking Statements

Certain statements in this release concerning our future growth prospects are forward-looking statements, within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The company uses words and phrases such as "guidance," "forecasted," "projects," "is expected," "remain confident," "will" and similar expressions to identify forward-looking statements in this press release, including forward-looking statements. Undue reliance should not be placed on forward-looking information. Forward-looking information is based on current expectations, estimates and projections that involve a number of risks, which could cause actual results to vary and in some instances to differ materially from those anticipated by Biostar and described in the forward-looking information contained in this news release. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the Company's ability to maintain its ongoing compliance with the Nasdaq continued listing requirements, success of our investments, risks and uncertainties regarding fluctuations in earnings, our ability to sustain our previous levels of profitability including on account of our ability to manage growth, intense competition, wage increases in China, its ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, its ability to successfully complete and integrate potential acquisitions, withdrawal of governmental fiscal incentives, political instability and regional conflicts and legal restrictions on raising capital or acquiring companies outside China. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our most recent Annual Report on Form 10-K for the year ended December 31, 2011, and other subsequent filings. These filings are available at www.sec.gov. We may, from time to time, make additional written and oral forward-looking statements, including statements contained in our filings with the Securities and Exchange Commission and our reports to shareholders. We do not undertake to update any forward-looking statements that may be made from time to time by or on our behalf.

For more information contact:




BioStar Pharmaceuticals, Inc. 

The Equity Group, Inc.

Zack Pan, CFO 

Lena Cati

Tel: 405-996-8829 

Tel: 212 836-9611

Email: zpan@aoxing-group.com

Email: lcati@equityny.com

SOURCE Biostar Pharmaceuticals, Inc.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
05:46p VAISALA OYJ : Share repurchase 23.1.2017
05:46p SIERRA INCOME CORPORATION : Supports Impact Sales’ Acquisition of Harlow-HRK Sales & Marketing, Inc.
05:45p ACKERMANS & VAN HAAREN : Redemption of shares
05:45p Carube Announces Private Placement
05:44p NQ MOBILE : NQ) Jumps on FL Mobile
05:44p Syncona Limited - Non-Mainstream Pooled Investments
05:44p COST SAVING OPPORTUNITIES FOR THE GLOBAL GMA MONOMERS 2016-2020 : Technavio
05:43p CARUBE COPPER : Announces Private Placement
05:43p Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Class Action Lawsuit Against TG Therapeutics, Inc. and Announces a Lead Plaintiff Deadline of March 7, 2017 – TGTX
05:43p CFP Board Promotes John M. Loper, CFP® to Managing Director of Professional Practice
Latest news
Advertisement
Hot News 
-2.55%PHILIPS LIGHTING : sees brighter 2017 as fourth-quarter profit disappoints
-7.90%LAMPRELL : Rig builder Lamprell sees lower revenue, tightens purse strings
-2.28%ESSENTRA : sees full-year operating profit near lower end of forecast
-1.57%Generali shares up 5 percent on report of Intesa, Allianz interest
0.62%L'OREAL : Founders Factory to invest in five cosmetics start-up firms
Most Read News
04:07a SAMSUNG ELECTRONICS : says batteries caused Note 7 fires, may delay new phone launch
09:35a TRUMP TO COMPANY EXECUTIVES : We think we can cut regulations by 75 percent
10:26a MCDONALD : U.S. sales drop for first time in six quarters
12:16aDJNEWS HIGHLIGHTS : Top Energy News of the Day
01:31a CGG : Reduction of certain vessel charter cash costs and related issuance of $58.6 million of senior notes
Most recommended articles
01/17DJS&P 500, Nasdaq Futures -- Technical Analysis
11:40a ANDREW LIVERIS : Liveris
11:38a MCDONALD : U.S. sales drop for first time in six quarters
11:37a ATR boss troubled by competition impact of Bombardier bailout
11:33a Trump tells manufacturers he will cut regulations, taxes